-+ 0.00%
-+ 0.00%
-+ 0.00%

Bionano Genomics Affirms FY2026 Sales Guidance of $30.000M-$33.000M vs $32.137M Est

Benzinga·05/13/2026 20:07:51
Listen to the news
Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $30.000 million-$33.000 million to $30.000 million-$33.000 million vs $32.137 million estimate.